4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[(2-methylphenyl)methyl]benzamide
Chemical Structure Depiction of
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[(2-methylphenyl)methyl]benzamide
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[(2-methylphenyl)methyl]benzamide
Compound characteristics
Compound ID: | L610-0087 |
Compound Name: | 4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[(2-methylphenyl)methyl]benzamide |
Molecular Weight: | 453.54 |
Molecular Formula: | C28 H27 N3 O3 |
Smiles: | Cc1ccccc1CNC(c1ccc(CN2C(C3CCCN3C(c3ccccc23)=O)=O)cc1)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 3.5256 |
logD: | 3.5255 |
logSw: | -3.6107 |
Hydrogen bond acceptors count: | 6 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 56.686 |
InChI Key: | JWSMHZJONVKMHH-VWLOTQADSA-N |